BIOMAT Database Logo BIOMAT Database Logo

[The cardiac glycoside treatment of circulatory insufficiency in the bradysystolic form of cardiac fibrillation]. 1967

N A Dolgoplosk, and M S Bazilevich

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002301 Cardiac Glycosides Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose. Cardiac Glycoside,Cardiotonic Steroid,Cardiotonic Steroids,Glycoside, Cardiac,Glycosides, Cardiac,Steroid, Cardiotonic,Steroids, Cardiotonic
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations

Related Publications

N A Dolgoplosk, and M S Bazilevich
[Cardiac glycoside treatment of rheumatic heart disease with circulatory insufficiency].
October 1979, Vrachebnoe delo,
N A Dolgoplosk, and M S Bazilevich
[Cardiac glycoside treatment of children with rheumatic fever and circulatory insufficiency].
April 1972, Voprosy okhrany materinstva i detstva,
N A Dolgoplosk, and M S Bazilevich
[CARDIAC GLYCOSIDE THERAPY IN CIRCULATORY INSUFFICIENCY IN MYOCARDIAL INFARCT].
May 1963, Klinicheskaia meditsina,
N A Dolgoplosk, and M S Bazilevich
[Characteristics of cardiac glycoside treatment of circulatory insufficiency in young children with acute pneumonia].
January 1976, Pediatriia,
N A Dolgoplosk, and M S Bazilevich
[Treatment of cardiac insufficiency with cardiac glycoside thevetin].
December 1955, Arztliche Wochenschrift,
N A Dolgoplosk, and M S Bazilevich
[Use of sirenid in the treatment of circulatory insufficiency in patients with cardiac fibrillation].
September 1965, Vrachebnoe delo,
N A Dolgoplosk, and M S Bazilevich
[Treatment of cardiac insufficiency with a new cardiac glycoside].
July 1965, Der Landarzt,
N A Dolgoplosk, and M S Bazilevich
[Use of glucagon in cardiac glycoside poisoning in patients with congestive circulatory insufficiency].
September 1977, Kardiologiia,
N A Dolgoplosk, and M S Bazilevich
[Treatment of cerebral circulatory insufficiency in latent cardiac insufficiency].
January 1970, Die Medizinische Welt,
N A Dolgoplosk, and M S Bazilevich
[Glycoside treatment characteristics in circulatory insufficiency with inflammatory processes in the heart].
October 1975, Kardiologiia,
Copied contents to your clipboard!